Drug-drug interactions of glecaprevir and pibrentasvir coadministered with human immunodeficiency virus antiretrovirals | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Drug-drug interactions of glecaprevir and pibrentasvir coadministered with human immunodeficiency virus antiretrovirals

Kosloski MP, Oberoi R, Wang S, et al. Drug-drug interactions of glecaprevir and pibrentasvir coadministered with human immunodeficiency virus antiretrovirals. J Infect Dis. 2020;221(2):223-231.

Publication Type:

Journal Article

Authors:

Kosloski, MP; Oberoi, R; Wang, S; et, al

Source:

J Infect Dis, Volume 221, Issue 2, p.223-231 (2020)

Cited On:

Patients With HIV/HCV Coinfection

Export Citation:

RIS Format

Top